Search research articles
Contact Us
Filters
Showing results (61-70 of 81) with videos related to
Page
of 9
Sort By:
The Journal of Biological Chemistry
|
January 4, 2020
Mass spectrometry-based selectivity profiling identifies a highly selective inhibitor of the kinase MELK that delays mitotic entry in cancer cells
Ian M McDonald, Gavin D Grant, Michael P East, et al.
The Journal of Pathology
|
January 19, 2012
Genomic and mutational profiling of ductal carcinomas in situ and matched adjacent invasive breast cancers reveals intra-tumour genetic heterogeneity and clonal selection
Lucia Hernandez, Paul M Wilkerson, Maryou B Lambros, et al.
Cancer Discovery
|
December 8, 2019
TBK1 Is a Synthetic Lethal Target in Cancer with <i>VHL</i> Loss
Lianxin Hu, Haibiao Xie, Xijuan Liu, et al.
Molecular Oncology
|
July 22, 2014
Integrative genomic and transcriptomic characterization of papillary carcinomas of the breast
Salvatore Piscuoglio, Charlotte K Y Ng, Luciano G Martelotto, et al.
Journal of Managed Care & Specialty Pharmacy
|
March 26, 2016
Impact of Clinical Pharmacy Specialists on the Design and Implementation of a Quality Improvement Initiative to Decrease Inappropriate Medications in a Veterans Affairs Emergency Department
Jason M Moss, William E Bryan, Loren M Wilkerson, et al.
The Journal of Pathology
|
October 26, 2011
Immunophenotypic and genomic characterization of papillary carcinomas of the breast
Raphaëlle Duprez, Paul M Wilkerson, Magali Lacroix-Triki, et al.
Breast Cancer Research : BCR
|
April 19, 2015
Integrative analyses identify modulators of response to neoadjuvant aromatase inhibitors in patients with early breast cancer
Elena López-Knowles, Paul M Wilkerson, Ricardo Ribas, et al.
Breast Cancer Research : BCR
|
March 22, 2012
Functional characterization of the 19q12 amplicon in grade III breast cancers
Rachael Natrajan, Alan Mackay, Paul M Wilkerson, et al.
Journal of Pharmacy Practice
|
December 27, 2017
An Interdisciplinary Academic Detailing Approach to Decrease Inappropriate Medication Prescribing by Physician Residents for Older Veterans Treated in the Emergency Department
Jason M Moss, William E Bryan, Loren M Wilkerson, et al.
Histopathology
|
February 13, 2013
Mutation profiling of adenoid cystic carcinomas from multiple anatomical sites identifies mutations in the RAS pathway, but no KIT mutations
Daniel Wetterskog, Paul M Wilkerson, Daniel N Rodrigues, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 81) with videos related to
Sort By:
Page
of 9
The Journal of Biological Chemistry
|
January 4, 2020
Mass spectrometry-based selectivity profiling identifies a highly selective inhibitor of the kinase MELK that delays mitotic entry in cancer cells
Ian M McDonald, Gavin D Grant, Michael P East, et al.
The Journal of Pathology
|
January 19, 2012
Genomic and mutational profiling of ductal carcinomas in situ and matched adjacent invasive breast cancers reveals intra-tumour genetic heterogeneity and clonal selection
Lucia Hernandez, Paul M Wilkerson, Maryou B Lambros, et al.
Cancer Discovery
|
December 8, 2019
TBK1 Is a Synthetic Lethal Target in Cancer with <i>VHL</i> Loss
Lianxin Hu, Haibiao Xie, Xijuan Liu, et al.
Molecular Oncology
|
July 22, 2014
Integrative genomic and transcriptomic characterization of papillary carcinomas of the breast
Salvatore Piscuoglio, Charlotte K Y Ng, Luciano G Martelotto, et al.
Journal of Managed Care & Specialty Pharmacy
|
March 26, 2016
Impact of Clinical Pharmacy Specialists on the Design and Implementation of a Quality Improvement Initiative to Decrease Inappropriate Medications in a Veterans Affairs Emergency Department
Jason M Moss, William E Bryan, Loren M Wilkerson, et al.
The Journal of Pathology
|
October 26, 2011
Immunophenotypic and genomic characterization of papillary carcinomas of the breast
Raphaëlle Duprez, Paul M Wilkerson, Magali Lacroix-Triki, et al.
Breast Cancer Research : BCR
|
April 19, 2015
Integrative analyses identify modulators of response to neoadjuvant aromatase inhibitors in patients with early breast cancer
Elena López-Knowles, Paul M Wilkerson, Ricardo Ribas, et al.
Breast Cancer Research : BCR
|
March 22, 2012
Functional characterization of the 19q12 amplicon in grade III breast cancers
Rachael Natrajan, Alan Mackay, Paul M Wilkerson, et al.
Journal of Pharmacy Practice
|
December 27, 2017
An Interdisciplinary Academic Detailing Approach to Decrease Inappropriate Medication Prescribing by Physician Residents for Older Veterans Treated in the Emergency Department
Jason M Moss, William E Bryan, Loren M Wilkerson, et al.
Histopathology
|
February 13, 2013
Mutation profiling of adenoid cystic carcinomas from multiple anatomical sites identifies mutations in the RAS pathway, but no KIT mutations
Daniel Wetterskog, Paul M Wilkerson, Daniel N Rodrigues, et al.
Page
of 9